chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sweating ( required her to change pajamas); dizziness; joints were locked; weak; all symptoms of the flu (cold and hot); fever; really tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating ( required her to change pajamas)), DIZZINESS (dizziness), JOINT LOCK (joints were locked), ASTHENIA (weak) and INFLUENZA LIKE ILLNESS (all symptoms of the flu (cold and hot)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F21A and 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included FLECAINIDE for Cardiac disorder, COLECALCIFEROL (VIT D3) for an unknown indication.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced HYPERHIDROSIS (sweating ( required her to change pajamas)), DIZZINESS (dizziness), JOINT LOCK (joints were locked), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (all symptoms of the flu (cold and hot)), PYREXIA (fever) and FATIGUE (really tired). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of taken 1 dosage form. On 18-Sep-2021, HYPERHIDROSIS (sweating ( required her to change pajamas)), DIZZINESS (dizziness), JOINT LOCK (joints were locked), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (all symptoms of the flu (cold and hot)), PYREXIA (fever) and FATIGUE (really tired) had resolved.            This case was linked to MOD-2021-324276 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Oct-2021: Follow-up received. Contact information Updated.
Initial reactions:  runny nose, voice cracking, throat clearing.   This was followed by substantial nasal congestion and some mild upper chest tightness.  After that stopped, I experienced an episode of very slow breathing.   After that I was okay for a few hours, then the nasal congestion, chest tightness and very slow breathing happened a second time.
Severe nausea Severe headache Severe chills Severe muscle aches  Severe side effects lasted 6 hrs. Worse than the flu which I?ve had twice. After that in bed 2 more days but not severe
This spontaneous report was received from a pharmacist and refers to a 56 years old patient of unknown gender. No medical history, concurrent conditions or concomitant therapies were reported. On 04-SEP-2015 (reported as "today"), the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # K010016, expiration date 05-AUG-2015, dose 0.5 ml, intramuscularly (anatomical location was not reported). No adverse effects were reported. Additional information has been requested.
pt recv vax 12NOV96 & 25MAR97 pt devel chickenpox;
G62.9 NEUROPATHY 7/31/2021 ATRIAL FIBRILLATION, UNSPECIFIED G62.9 NEUROPATHY 7/31/2021 MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD
LEG CRAMPS; SHORTNESS OF BREATH; HEADACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced leg cramps. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the leg cramps, shortness of breath and headaches was not reported. This report was non-serious.
Upon awakening 16 hours after receiving injection the patient experienced significant vertigo and was fatigued despite sleeping 8+ hours. Remained in bed until 5:00 pm, mostly asleep. Lack of appetite, slight fever. Retired early. Symptoms gone by next morning, 10/11/23. Patient remembers these same symptoms happened with previous Covid shot, 9/12/22, Pfhizer Bi lot GH9694
Excruciating headache Fever 102 Complete body aches-Muscle and joints Nausea Dizziness Injection site pain, couldn?t move arm for 4 days Fatigue  Started 6-8 hours post vaccine and lasted for 48 hours
Gave patient HPV (first dose) on right deltoid at 11:55 am and patient walked out of room feeling ok, after 1 minute pt. fell down dizzy and turned pale from her face, assisted patient and gave her water and a lollipop, after 20 minutes of being in office checked her blood pressure and was 105/65. Pt was stable and left stable and alert.
Red splotchy 3x3 circle at site ,, hot and itchy ,, just started on  10th day after vaccine
I have had a rash for four months after getting my booster; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: RASH (non-serious), outcome "unknown", described as "I have had a rash for four months after getting my booster".  Additional information: Rash four month. Patient had a rash for four months after getting booster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHEH2014US004074 is an initial spontaneous report received from a pharmacist on 25 FEB 2014. This report refers to a 16-year-old patient of unknown gender. The medical history and concomitant medication of the patient was not reported. On an unknown date in FEB 2014, the patient was vaccinated with FLUCELVAX (batch number: 004011A) intramuscularly at a dose of 0.5 ml. No adverse event was reported following this administration error (inappropriate age at vaccine administration).  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 26 FEB 2014. The BPI labeling of the event "inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population".
pt recv vax & exp local rxn;rxn described as swelling @ vax site;recovered;this pt was the reporting MD;addtl info recv 28AUG95 revealed that the pt devel inj site rxn 24hr p/vax & was hyperemic, warm & indurated 2x2cm in size;
Swollen right deltoid, red ring on surface of the skin about the size of a quarter, tingling of fingers.
Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product AMANTADINE HYDROCHLORIDE (GOCOVRI) for Dyskinesia.    The patient's past medical history included Dystonia, Hepatic cirrhosis (From being a fatty liver), Hereditary hemochromatosis since an unknown date, Fibromyalgia, Arthritis and Hepatic steatosis. Previously administered products included for Immunisation: flu vaccine (Rash from flu shot resolved; primary care provider told her it had nothing to do with the flu shot. Rash subsequently resolved.) in September 2020 and tetanus (tet/dip tox (tetanus and diphtheria toxoids)); for Drug therapy: penicillin (Hypersensitivity) and sulfa; for an unreported indication: COVID-19 VACCINE (Second shot) on 03-Mar-2021. Past adverse reactions to the above products included Drug hypersensitivity with penicillin and sulfa; Hypersensitivity with tetanus; and Rash with flu vaccine. Concurrent medical conditions included Parkinson's disease (receiving levodopa-based therapy) and Dyskinesia (Receiving levodopa-based therapy). Concomitant products included DULOXETINE, AMITRIPTYLINE, TIZANIDINE, DESMOPRESSIN ACETATE, GABAPENTIN, PREGABALIN, LOSARTAN POTASSIUM, AMLODIPINE BESYLATE, OXYCODONE, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE BITARTRATE AND ACETAMINOPHEN), VITAMIN D NOS and MELOXICAM from an unknown date to 17-Mar-2021 for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient started AMANTADINE HYDROCHLORIDE (GOCOVRI) (Oral) 274 mg at bedtime. On 05-Feb-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She did take Benadryl for a couple days after both doses of vaccine, but that didn't really seem to effect it.   This case was linked to MOD-2021-065736 (Patient Link).
This consumer report (initial receipt: 23-Jan-2013) concerns a 68-year-old male patient, who had a medical history of high cholesterol. Concomitant medication included lovastatin. On 10-Sep-2012 the patient received a flu shot (manufacturer and batch number not specified) and ZOSTAVAX (batch number not specified). On 21-Sep-2012 the patient was bright red from the chest down, almost purple, had blisters the size of golf balls on his legs and groin and was on fire from the waist down. He was hospitalised for 4 nights. The outcome was not reported.
Injection around 9:30 am began itching at 10:00 am. Full hives around 10:30, swollen eyes scratchy throat, wheezing. Took over counter Benadryl - no help. Passed out taken to ER - rev'd Epi-pen, IV Prednisone, Benadryl breathing at treatments
27SEP96 pt exp urticaria;given med referred to urgent care ;MD eval;DPH tried p/48hr of urgent care visit;4OCT96 pt recovered;
A 54 year old male patient experienced chills and sweats while being treated with RabAvert for a bat bite. He received his second dose of RabAvert on 07/26/04. His medical history was significant for increased cholesterol and hypertension. Concomitant medications included Prevacid, Lisinopril with HCTZ and Lipitor. On the evening of 077/26/04, after his second dose of RabAvert, the patient developed chills and sweats which lasted about 40 minutes and resolved. The patient did not require treatment for the event and was reported as doing well. He was scheduled to received his next vaccination. The reporter did not assess causality between the events and the drug.
Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old, male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route on 14Apr2021 at 10:00 in the left arm (at an age of 30-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient received daily vitamins (MANUFACTURER UNKNOWN) within 2 weeks of COVID-19 vaccine for an unknown indication. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 24Mar2021 at 10:00 in the left arm as single dose for COVID-19 immunisation. On 14Apr2021 at 18:00, the patient experienced severe headache. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of severe headache was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient fainted in chair approximately 1-2 minutes after receiving Tdap vaccination--nurse had water bottle in cabinet and quickly sprinkled water over him while he slumped in chair against wall; nurse also applied wet & cold paper towels to patient's face/neck/arms.  Patient regained consciousness after a couple of minutes.  At no time did patient fall or strike any object or any part of the room/furniture.  Cold pack was applied to patient's face/neck/arms, and patient ate lollipop.  After ~25 minutes, nurse walked patient to waiting room to wait until he felt able to leave on his own--RN
Pfizer vaccine was administered outside of Facility- reported by patient- ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------------------------- J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/7/2022 CARDIAC ARREST DUE TO UNSPECIFIED CAUSE R57.0 CARDIOGENIC SHOCK 2/7/2022 CARDIAC ARREST DUE TO UNSPECIFIED CAUSE
Back of neck started hurting within the 15 mins she had to sit after taking the vaccine. She was told she could go home and take Tylenol. The next damn she stated the pain grew increasingly from her hip to the back of her knees all on the left side. She can barely walk without holding on to something.
INCREASING CHILLS; MILD PAIN AT INJECTION SITE; UNUSUALLY INTENSE TIREDNESS; LOW GRADE FEVER; HEADACHE; NAUSEA; UNABLE TO SLEEP; UNABLE TO EAT; VOMITING; This spontaneous report received from a patient concerned a 27 year old. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced unable to sleep. On APR-2021, the subject experienced unable to eat. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced low grade fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced increasing chills. On 10-APR-2021, the subject experienced mild pain at injection site. On 10-APR-2021, the subject experienced unusually intense tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from increasing chills, unusually intense tiredness, low grade fever, headache, nausea, vomiting, unable to sleep, and unable to eat, and had not recovered from mild pain at injection site. This report was non-serious.
At first the patient presented severe arm pain. After that the patient resemble a clinical diagnosis similar to a panic attack. Among the adverse effects present were: stomach pain, arm pain, headaches, respiratory distress and trembling.  We sat the patient outside the store so she could take fresh air away from people. After that she deteriorated and we had to administer oxygen. We called the ambulance multiple times to no avail. Husband took her to a nearby hospital assisted. After an hour we called and the MD said she vomited but is now stable.
My right arm where I received the vaccine, is so sore I can hardly use it. Also I can?t reach over my head anymore, also the pain keeps me awake at night so now I have trouble sleeping.  I now after the vaccine have a knot in the right side of my neck.
Chest pain, shortness of breath presenting symptoms. Tachycardic rate 150.
Two days after my 2nd dose I exhibited severe pelvic cramping along with pain in both ovaries. The pain lasted for about an hour where I was unable to lay down, sit up or stand up without convulsing. There were muscle spasms, exhibited lots of shivering and cold. I treated this with Tylenol and it did not help immediately. After the hour I was able to lay down and go to sleep with the pelvic area still sore but not in as much pain as previously stated. The next two days I exhibited soreness in the pelvic and ovary areas. Currently I am experiencing no pain.
Patient reports blood in urine 4 days after receiving the 1st dose of Moderna Vaccine.  He was seen by his Dr and was advised that it was unlikely that vaccine caused the bleeding, and treated patient for a UTI and told him if further bleeding occurred that he would perform a Cystoscopy.  Patient states he had mild tenderness over 1 kidney the day after the bleeding and no further issues.  Patient was treated with antibiotics for UTI.
This is a follow-up spontaneous report from a contactable consumer (patient). A 58-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on Mar 5, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient previously took Zithromax and experienced allergies. She wanted to know if her doctor does not recommend getting the 2nd dose, how effective is the 1st dose. Patient is allergic to Zithromax. She wanted to know if Zithromax and Pfizer COVID-19 vaccine have the same ingredients (as she had experienced reactions on both medications). She is aware of the ingredients of the Pfizer COVID-19 vaccine. She is scheduled to get her 2nd dose on Apr 2, 2021 (scheduled more than 21 days). She wanted to know if she can take her 2nd dose under 21 days or if she can reschedule her appointment. On an unspecified date in Mar 2021, patient experienced itching around her foot. Therapeutic measures taken because of itching around her foot: Benadryl. The outcome of event: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
after threw up she administered the moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (after threw up she administered the moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (after threw up she administered the moderna vaccine). At the time of the report, INCORRECT DOSE ADMINISTERED (after threw up she administered the moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
103.5 Fever, chills, convulsions, nerve pain radiating into elbow, hand and left pinky and ring fingers, numbness and tingling in left pinky and ring fingers, vomiting, chest tightness and mild asthmatic reaction, joint pain, muscle soreness.
DTaP-local reaction 5" x 4" day. Fever-103.7 3-4 days. CBC WBC 3.3 platelets 120.
my arm swelled; red, and tenderness at injection site.; red, and tenderness at injection site.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Aug2021 14:00 (Lot number: FD8448) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergy: sulfa" (unspecified if ongoing). Concomitant medication(s) included: PROZAC; OMEPRAZOLE. Past drug history included: Iodine, reaction(s): "Known allergy". The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 23Aug2021, outcome "recovering", described as "my arm swelled"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 23Aug2021, outcome "recovering" and all described as "red, and tenderness at injection site.". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site erythema, vaccination site pain. No follow-up attempts are possible. No further information is expected.
Client States right arm swollen, reddened, fifty cent size hardened area in area of vaccination.  Experienced headache, fever of 100.1, Symptoms still present 12/19/2011 when she saw Dr.  Dr. prescribed Sulsameth BID.
Feverish; Sore shoulder; This is a spontaneous report from a contactable consumer or other non-HCP (this report is for the reporter's father). A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW017, Expiry Date of COVID Vaccine: Unknown) via an unspecified route of administration administered in the arm right (reported as "right shoulder") on 21Apr2021 as DOSE 1, SINGLE (at the age of 45-years-old) for COVID-19 immunization. Medical history included ongoing blood pressure abnormal Verbatim: Blood pressure. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced feverish, sore shoulder. No treatment was given for the reported events. No investigation assessment. The outcome of event events feverish and sore shoulder were unknown.  No follow-up attempts are possible; no further information is expected.
symptoms: knot in chest around sternum area, profuse sweating, lightheadedness, increased breathing.  called 911 went to local hospital. had cardiac workup (EKG, blood tests, chest x-ray) negative for heart attack. released in evening. follow-up scheduled with primary care doc.
Doses given >12 hours post vial puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses given >12 hours post vial puncture) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses given >12 hours post vial puncture). On 16-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Doses given >12 hours post vial puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product was reported. The pharmacist reported that they had a vial on Moderna that was punctured at 10:45am on 15-Nov-2021. This vial was kept at room temperature and doses were drawn after 12 hours. Two doses were given the next day from the punctured vial. On 16-Nov-2021 administration of 1 vaccine at 1:35PM, 26hrs, 50mins at room temperature. On 16-Nov-2021 administration of 2 vaccine at 4:30PM, 29hrs, 45mins at room temperature.